Reuters SG
Brazilian medicine and drug wholesaler Viveo said on Wednesday it has priced a share sale comprising both primary and secondary offerings at 21.21 reais per share, a 2.1% discount over its Tuesday closing price. Viveo said in a securities filing it is selling 36.7 million new shares as part of the primary offering, while existing shareholder Genoma VI, an investment fund, will sell 21 million shares from its stake in the company. That would make the offer total 1.22 billion reais ($254.56 million).